NCT00686543View on ClinicalTrials.gov

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Fungal InfectionAcute Myelogenous LeukemiaNeutropenia
Interventions
DRUG

Posaconazole

Posaconazole will be used for prophylaxis

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00686543 - Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) | Biotech Hunter | Biotech Hunter